123 related articles for article (PubMed ID: 10523350)
1. L-arginine restores the effect of ouabain on baroreceptor activity and prevents hypertension.
Abreu GR; Futuro-Neto HA; Cabral AM; Vasquez EC
Hypertension; 1999 Oct; 34(4 Pt 2):729-32. PubMed ID: 10523350
[TBL] [Abstract][Full Text] [Related]
2. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
[TBL] [Abstract][Full Text] [Related]
3. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
Alvarez G; Osuna A; Wangensteen R; Vargas F
Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide influences blood flow distribution in renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1994 Jan; 23(1 Suppl):I34-9. PubMed ID: 8282373
[TBL] [Abstract][Full Text] [Related]
5. Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats.
Rossoni LV; Pinto VD; Vassallo DV
Braz J Med Biol Res; 2001 Aug; 34(8):1065-77. PubMed ID: 11471047
[TBL] [Abstract][Full Text] [Related]
6. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
[TBL] [Abstract][Full Text] [Related]
7. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.
DE Gracia MC; Osuna A; O'Valle F; Del Moral RG; Wangensteen R; Del Rio CG; Vargas F
J Am Soc Nephrol; 2000 Nov; 11(11):1995-2000. PubMed ID: 11053474
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
9. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
10. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
[TBL] [Abstract][Full Text] [Related]
11. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Delacrétaz E; Zanchi A; Nussberger J; Hayoz D; Aubert JF; Brunner HR; Waeber B
Hypertension; 1995 Aug; 26(2):332-6. PubMed ID: 7543453
[TBL] [Abstract][Full Text] [Related]
12. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
[TBL] [Abstract][Full Text] [Related]
13. Decreased influence of nitric oxide on deoxycorticosterone acetate (DOCA)-salt hypertension.
Ayangade-Johnson O; Joshua IG
Am J Hypertens; 2001 Apr; 14(4 Pt 1):387-9. PubMed ID: 11336187
[TBL] [Abstract][Full Text] [Related]
14. Ouabain produces diverse excitatory effects on afferent baroreceptor nerve activity in SHR and WKY animals.
Abreu GR; Futuro Neto HA; Cabral AM; Vasquez EC
Clin Exp Hypertens; 1998 Jan; 20(1):85-94. PubMed ID: 9507790
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide at the CVLM is involved in the attenuation of the reflex bradycardia in renovascular hypertensive rats.
de Castro UG; de Sousa GG; Machado Rdo P; Isoldi MC; Silva ME; Nadu AP; Sousa LE; Santos RA; Campagnole-Santos MJ; Alzamora AC
Nitric Oxide; 2012 Feb; 26(2):118-25. PubMed ID: 22265789
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived relaxing factor responses in Doca-salt hypertensive rats.
Kirchner KA; Scanlon PH; Dzielak DJ; Hester RL
Am J Physiol; 1993 Sep; 265(3 Pt 2):R568-72. PubMed ID: 8214147
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
18. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats.
Hayakawa H; Hirata Y; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M
Hypertension; 1994 Jun; 23(6 Pt 1):752-6. PubMed ID: 8206573
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-NAME and L-Arg on arterial blood pressure in normotensive and hypertensive streptozotocin diabetic rats.
Costa MA; Balaszczuk AM; Domínguez A; Catanzaro O; Arranz C
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):59-63. PubMed ID: 9695876
[TBL] [Abstract][Full Text] [Related]
20. Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1993 Aug; 22(2):237-42. PubMed ID: 8340159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
